Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling

Jinfeng Wu(Fudan University), Zhi‐Ling Yu(Hong Kong Baptist University)
Oncotarget
June 13, 2016
Cited by 38


Related Papers